PUBLIC CONTRACT · 2025
Aquisição de RIPRETINIB ORAL 50MG COMP (AUE 202500356) ao Lab. Clinigen para a ULSASI para o ano de 2025
- Contract value
- €258,000.00
- Signed on
- 3 March 2025
- Procedure
- Contratação excluída II
This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.
Record 15194634PUBLISHED DESCRIPTION
10E0250625
Parties involved
- Awardee
- - - CLINIGEN HEALTHCARE LDA
- Place of performance
- Portugal, Lisboa, Amadora
- NUTS region
- Not stated
WHO BID
Awardee and competitors
Companies that IMPIC lists as the awardee and as competitors in this procedure.
- Awardee
- - - CLINIGEN HEALTHCARE LDA
- Bidder
- --CLINIGEN HEALTHCARE LDA
Values and timeline
- Contract price
- €258,000.00
- Procedure base price
- €258,000.00
- Total effective price
- Not reported on Portal BASE
- Publication date
- 24 June 2026
- Award date
- 27 February 2025
- Signing date
- 3 March 2025
- Performance period
- 303 days
The contract price is the value agreed in the contract, not the amount paid.
Procedure and framework
- Contract type
- Aquisição de bens móveis
- Procedure type
- Contratação excluída II
- Award criterion
- Monofator
- CPV code
- 33600000-6 - Produtos farmacêuticos
- Legal basis
- artigo 5.º n.º 1 do Código dos Contratos Públicos
- Regime
- Código dos Contratos Públicos (DL111-B/2017) e Lei n.º 30/2021, de 21.05
- Framework agreement
- Not stated
- Centralised procedure
- No
- Environmental criterion
- No
- Notice
- Not stated
- Procedure identifier
- 7495265
Compare with other contracts
Search the same body, supplier, place or type of service to understand the context of the published index.